115 related articles for article (PubMed ID: 8118875)
41. Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones.
Birch MA; Skerry TM
Bone; 1999 Jun; 24(6):571-8. PubMed ID: 10375199
[TBL] [Abstract][Full Text] [Related]
42. Syndecan-1/CD138 expression in normal myeloid, acute lymphoblastic and myeloblastic leukemia cells.
Seftalioglu A; Karakus S
Acta Histochem; 2003; 105(3):213-21. PubMed ID: 13677614
[TBL] [Abstract][Full Text] [Related]
43. Regulation of epithelial syndecan-1 expression by inflammatory cytokines.
Day RM; Mitchell TJ; Knight SC; Forbes A
Cytokine; 2003 Mar; 21(5):224-33. PubMed ID: 12824007
[TBL] [Abstract][Full Text] [Related]
44. Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages.
Yeaman C; Rapraeger AC
J Cell Biol; 1993 Aug; 122(4):941-50. PubMed ID: 8394371
[TBL] [Abstract][Full Text] [Related]
45. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas.
Sebestyén A; Berczi L; Mihalik R; Paku S; Matolcsy A; Kopper L
Br J Haematol; 1999 Feb; 104(2):412-9. PubMed ID: 10050727
[TBL] [Abstract][Full Text] [Related]
46. The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells.
Jourdan M; Ferlin M; Legouffe E; Horvathova M; Liautard J; Rossi JF; Wijdenes J; Brochier J; Klein B
Br J Haematol; 1998 Mar; 100(4):637-46. PubMed ID: 9531328
[TBL] [Abstract][Full Text] [Related]
47. Growth factors induce 3T3 cells to express bFGF-binding syndecan.
Elenius K; Määttä A; Salmivirta M; Jalkanen M
J Biol Chem; 1992 Mar; 267(9):6435-41. PubMed ID: 1556147
[TBL] [Abstract][Full Text] [Related]
48. The role of syndecan-1 in malignancies.
Inki P; Jalkanen M
Ann Med; 1996 Feb; 28(1):63-7. PubMed ID: 8932508
[TBL] [Abstract][Full Text] [Related]
49. [Induction of syndecan-1 expression in parietal cells during gastric mucosal injury by NSAIDs].
Yokota K; Satoh T
Nihon Rinsho; 2002 Feb; 60 Suppl 2():217-21. PubMed ID: 11979781
[No Abstract] [Full Text] [Related]
50. Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia.
Sebestyén A; Kovalszky I; Mihalik R; Gallai M; Bocsi J; László E; Benedek S; Sréter L; Kopper L
Eur J Cancer; 1997 Nov; 33(13):2273-7. PubMed ID: 9470818
[TBL] [Abstract][Full Text] [Related]
51. Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent.
Leppä S; Vleminckx K; Van Roy F; Jalkanen M
J Cell Sci; 1996 Jun; 109 ( Pt 6)():1393-403. PubMed ID: 8799827
[TBL] [Abstract][Full Text] [Related]
52. Binding of human syndecan to extracellular matrix proteins.
Elenius K; Salmivirta M; Inki P; Mali M; Jalkanen M
J Biol Chem; 1990 Oct; 265(29):17837-43. PubMed ID: 1698781
[TBL] [Abstract][Full Text] [Related]
53. Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading.
Carey DJ; Stahl RC; Cizmeci-Smith G; Asundi VK
J Cell Biol; 1994 Jan; 124(1-2):161-70. PubMed ID: 8294499
[TBL] [Abstract][Full Text] [Related]
54. Characterization of the high affinity cell-binding domain in the cell surface proteoglycan syndecan-4.
McFall AJ; Rapraeger AC
J Biol Chem; 1998 Oct; 273(43):28270-6. PubMed ID: 9774449
[TBL] [Abstract][Full Text] [Related]
55. Reduction of syndecan-1 mRNA in cervical-carcinoma cells is involved with the 3' untranslated region.
Nakanishi K; Yoshioka N; Oka K; Hakura A
Int J Cancer; 1999 Feb; 80(4):527-32. PubMed ID: 9935152
[TBL] [Abstract][Full Text] [Related]
56. Expression of syndecan-1 inhibits cell invasion into type I collagen.
Liebersbach BF; Sanderson RD
J Biol Chem; 1994 Aug; 269(31):20013-9. PubMed ID: 8051085
[TBL] [Abstract][Full Text] [Related]
57. Syndecan-1 expression suppresses the level of myeloma matrix metalloproteinase-9.
Kaushal GP; Xiong X; Athota AB; Rozypal TL; Sanderson RD; Kelly T
Br J Haematol; 1999 Feb; 104(2):365-73. PubMed ID: 10050721
[TBL] [Abstract][Full Text] [Related]
58. Altered proliferative and metastatic potential associated with increased expression of syndecan-1.
Hirabayashi K; Numa F; Suminami Y; Murakami A; Murakami T; Kato H
Tumour Biol; 1998; 19(6):454-63. PubMed ID: 9817973
[TBL] [Abstract][Full Text] [Related]
59. Syndecan-1 (CD138) expression in acute myeloblastic leukemia cells--an immuno electron microscopic study.
Seftalioglu A; Karakus S; Dundar S; Can B; Erdemli E; Irmak MK; Oztas E; Korkmaz C; Yazar F; Cavusoglu I
Acta Oncol; 2003; 42(1):71-4. PubMed ID: 12665334
[TBL] [Abstract][Full Text] [Related]
60. Syndecan, a cell surface proteoglycan, exhibits a molecular polymorphism during lung development.
Brauker JH; Trautman MS; Bernfield M
Dev Biol; 1991 Oct; 147(2):285-92. PubMed ID: 1916010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
